05.11.2014 Views

annual Report 2009 - STRATEC Biomedical AG

annual Report 2009 - STRATEC Biomedical AG

annual Report 2009 - STRATEC Biomedical AG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Report</strong> of the board of Management<br />

<strong>Report</strong> of the supervisory board<br />

THE share<br />

Corporate Governance<br />

Group Management report<br />

Consolidated financial statements<br />

Service<br />

Financial expenses are structured as follows:<br />

in v thousand IAS 39 categories* <strong>2009</strong> 2008<br />

Interest expenses on loan liabilities to banks<br />

(current and non-current) LMAC 195 199<br />

Interest expenses on typical silent partnerships LMAC 18 0<br />

Interest expenses on other current financial liabilities LMAC 1 25<br />

Total 214 224<br />

Other financial income/expenses include gains and losses on financial assets and financial liabilities measured at fair<br />

value and are structured as follows:<br />

in v thousand IAS 39 categories* <strong>2009</strong> 2008<br />

Gains / losses on financial assets measured at fair value<br />

through profit or loss:<br />

Interest and dividends 0 8<br />

Gains / losses on retirement 0 0<br />

Gains / losses on measurement at balance sheet date 361 -131<br />

Gains / losses on financial assets measured at fair value in equity:<br />

AHfT<br />

361 -123<br />

Interest and dividends 0 0<br />

Gains / losses on retirement 188 0<br />

Gains / losses on measurement at balance sheet date 0 -2,075<br />

Income / expenses on financial liabilities measured at fair value<br />

through profit or loss:<br />

AfS<br />

188 -2,075<br />

Interest and dividends 0 -52<br />

Gains / losses on retirement 0 63<br />

Gains / losses on measurement at balance sheet date 0 0<br />

LHfT<br />

0 11<br />

Total 549 -2,187<br />

* Reference is made to the information provided in Section VII “Financial instruments / Risk management” with regard to the IAS 39 categories and the abbreviations<br />

used here. Changes upon measurement of available-for-sale financial instruments as of the balance sheet date must be recognized through profit or loss when the fair<br />

value shows a significant or permanent impairment.<br />

stratec Annual <strong>Report</strong> <strong>2009</strong><br />

95

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!